Latest News Archive

Please select Category, Year, and then Month to display items
Categories
UFS News Media Release Research
Years
2017 2018 2019 2020 2021 2022 2023 2024
Months
January February March April May June July August September October November December
Previous Archive
21 June 2019 | Story Valentino Ndaba | Photo Ernst & Young
UFS Accounting Students win EY Project Alpha
At the Ernst & Young Project Alpha 2019 Awards, some of the members of the winning team, from left: Kyle du Bruyn, Luke Rhode, Janri du Toit, Nicolaas van Zyl, Mojalefa Mosala (Business Ethics Lecturer), Bianca Malan, Lorandi Koegelenberg and Frans Benecke.
A few years ago the news was saturated with Volkswagen’s (VW) fuel emission scandal. “Dieselgate”. Investigations in the US found the German automaker guilty of programming computers in their diesel cars to alter its engine operations to seemingly meet legal emission standards.

A question of ethics

A notice of violation of the Clean Air Act issued by the US Environmental Protection Agency had dire consequences for the automobile company, but positive implications for the economy and the environment. As part of a lawsuit settlement, vehicles were recalled, fines were paid, and approximately 21 million affected vehicles with VW diesel engines were refitted by September 2015.

Project Alpha tackles ethical issues

A group of eight students from the University of the Free State (UFS) presented their case study of “Dieselgate” to a panel of judges in this year’s Ernst & Young Project Alpha competition. They emerged as the ultimate winners.

The “Hoaxwagen” group’s 10-minute video demonstrated “a critical assessment of a multidimensional matter”   captivating the judges. “I was impressed, because their presentation addressed other skills such as the ability to present, communicate, come out of their comfort zone and be innovative, while at the same time addressing an ethical issue,” said Mojalefa Mosala, a judge and Business Ethics lecturer at the UFS.

Centred on critical thinking

The UFS is the first university outside of Johannesburg that participated in the Project Alpha contest. Ernst & Young and the UFS have forged a strong relationship over the past few years, giving students a glimpse into the corporate world of accounting. 

“Project Alpha encourages critical thinking and not taking things at face value, by looking a bit deeper, spending time to understand the pros and cons of any situation in order to make an informed decision,” said Frans Benecke, member. of the winning team that prevailed over 82 others. Benecke’s team walked away with R2000 shopping vouchers and a life-long learning experience.

Engaging in global conversations 

Participation in the competition gave students the opportunity to be exposed to contemporary global thinking, which is strongly advocated in the UFS’s Integrated Transformation Plan.


UFS Accounting students win 2019 Ernst & Young Project Alpha competition from University of the Free State on Vimeo.

News Archive

DNA sequencer launched at the UFS
2013-11-25

Dr Gansen Pillay, Deputy Chief Executive Officer of the National Research Foundation, explaining to the scholars what will be expected of them.

The University of the Free State (UFS) can now collect immensely valuable data on drug resistance in HIV/Aids and TB with the new DNA sequencer that was launched recently at the International workshop on HIV/AIDS and TB drug resistance at the Bloemfontein Campus.

The DNA sequencer will allow the Free State province to produce viral and bacterial genetic data to fight the local development of HIV/ Aids and TB drug resistance.

The HIV and TB epidemics have expanded very fast and South Africa now has the largest HIV and TB treatment programme in the world, with over 2 million patients on treatment. However, these successful treatment programmes are now being threatened by the appearance of drug resistance.

The Free State province has been at the forefront of fighting HIV drug resistance in South Africa and has one of the most advanced treatment programmes for the management of resistance strains in the country. In addition, researchers at the University of the Free State are leading partners in the Southern African Treatment and Resistance Network (SATuRN; www.bioafrica.net/saturn), a research network that has trained over 2 000 medical officers in the treatment of drug resistance strains.

The Department of Medical Microbiology and Virology in the Medical School at the UFS has partnered with the provincial department of health, the Medical Research Council (MRC) and the Delegation of the European Union to South Africa to fund a dedicated DNA sequencer machine that will be used to generate HIV and TB drug-resistance results. This new machine will enable cutting-edge research to take place, using the data in the province and, importantly, support patients with resistance strains to have access to advanced genotypic testing techniques.

“HIV drug resistance is a very serious problem in South Africa, and the recent advances in DNA testing technology allow clinicians in the province to access drug resistance testing, which enables them to manage patients appropriately who fail treatment, and use the results to cost-effectively extend and improve patients’ lives,” says Dr Cloete van Vuuren, Specialist in Infectious Diseases at the UFS’s Faculty of Health.

Dr Dominique Goedhals, pathologist from the Department of Medical Microbiology and Virology at the UFS, adds: “We have been looking forward to expanding our work with the clinicians and researchers, using DNA sequencing to shed light on the causes and consequences of drug resistance in urban and rural settings in the province.”

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept